Ptc Therapeutics (PTCT) Finished Goods (2019 - 2026)
Ptc Therapeutics (PTCT) posted quarterly Finished Goods of $23.1 million for Q2 2026, up 207.15% year-over-year from $7.5 million in Q2 2025, and up 8.94% quarter-over-quarter from $21.2 million in Q1 2026.
Ptc Therapeutics (PTCT) Finished Goods (2019 - 2026) Analysis & Trends
Ptc Therapeutics' Finished Goods history runs 8 years deep, the most recent figure standing at $23.1 million for Q2 2026.
- In Q2 2026, Finished Goods rose 207.15% year-over-year to $23.1 million; the TTM figure through Jun 2026 stood at $23.1 million (up 207.15% YoY), while the FY2025 annual figure was $21.7 million, up 156.75% from the prior year.
- Finished Goods for Q2 2026 stood at $23.1 million, up from $21.2 million in the prior quarter.
- The five-year high for Finished Goods was $23.1 million in Q2 2026, with the low at $5.7 million in Q1 2022.
- The 5-year median for Finished Goods is $8.0 million (2024), against an average of $10.2 million.
- The sharpest annual moves came in 2024 and 2026: Finished Goods plunged 33.45% in 2024, then soared 225.27% in 2026.
- Ptc Therapeutics' Finished Goods stood at $6.7 million in 2022, then soared by 74.79% to $11.6 million in 2023, then declined by 27.45% to $8.4 million in 2024, then jumped by 156.75% to $21.7 million in 2025, then advanced by 6.41% to $23.1 million in 2026.
- Business Quant data shows PTCT's Finished Goods at $23.1 million in Q2 2026, $21.2 million in Q1 2026, and $21.7 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Ptc Therapeutics | 5.97 Bn | 3.75 Bn | 340.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 23.06 Mn |
| Mar 31, 2026 | 21.17 Mn |
| Dec 31, 2025 | 21.67 Mn |
| Sep 30, 2025 | 8.62 Mn |
| Jun 30, 2025 | 7.51 Mn |
| Mar 31, 2025 | 6.51 Mn |
| Dec 31, 2024 | 8.44 Mn |
| Sep 30, 2024 | 8.49 Mn |
| Jun 30, 2024 | 6.68 Mn |
| Mar 31, 2024 | 6.76 Mn |
| Dec 31, 2023 | 11.63 Mn |
| Sep 30, 2023 | 10.25 Mn |
| Jun 30, 2023 | 10.04 Mn |
| Mar 31, 2023 | 7.11 Mn |
| Dec 31, 2022 | 6.66 Mn |
| Sep 30, 2022 | 6.51 Mn |
| Jun 30, 2022 | 6.59 Mn |
| Mar 31, 2022 | 5.71 Mn |
| Dec 31, 2021 | 6.72 Mn |
| Sep 30, 2021 | 6.13 Mn |